vs
Side-by-side financial comparison of Solana Co (HSDT) and Opus Genetics, Inc. (IRD). Click either name above to swap in a different company.
Solana Co is the larger business by last-quarter revenue ($5.2M vs $3.9M, roughly 1.4× Opus Genetics, Inc.). On growth, Solana Co posted the faster year-over-year revenue change (2725.9% vs -10.2%). Over the past eight quarters, Solana Co's revenue compounded faster (522.3% CAGR vs 50.3%).
Solana is a Mexican cottage manufacturer of sports, racing, and kids' automobiles based in Mexico City. The family run company has operated since 1936, with a total production of fewer than fifty cars; the majority of them one-offs. The family is heavily involved in motor sports; the most prominent member was Moisés Solana, who raced family-built cars and later in Formula One.
Opus Genetics, Inc. is a clinical-stage biotechnology company specializing in the development of targeted gene therapies for inherited retinal diseases. It focuses on addressing unmet medical needs for patients living with rare, vision-threatening ocular conditions, with operations centered on advancing accessible therapeutic candidates for global rare disease patient populations.
HSDT vs IRD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.2M | $3.9M |
| Net Profit | $325.6M | — |
| Gross Margin | 96.6% | — |
| Operating Margin | -3845.8% | — |
| Net Margin | 6227.1% | — |
| Revenue YoY | 2725.9% | -10.2% |
| Net Profit YoY | 8388.0% | 53.0% |
| EPS (diluted) | $111.28 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $5.2M | $3.9M | ||
| Q3 25 | $697.0K | $3.1M | ||
| Q2 25 | $43.0K | $2.9M | ||
| Q1 25 | $49.0K | $4.4M | ||
| Q4 24 | $185.0K | $4.3M | ||
| Q3 24 | $51.0K | $3.9M | ||
| Q2 24 | $182.0K | $1.1M | ||
| Q1 24 | $135.0K | $1.7M |
| Q4 25 | $325.6M | — | ||
| Q3 25 | $-352.8M | $-17.5M | ||
| Q2 25 | $-9.8M | $-7.4M | ||
| Q1 25 | $-3.8M | $-8.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-3.7M | $-7.5M | ||
| Q2 24 | $-1.6M | $-7.8M | ||
| Q1 24 | $-2.5M | $-7.1M |
| Q4 25 | 96.6% | — | ||
| Q3 25 | 85.2% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 16.8% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 35.2% | — | ||
| Q1 24 | 8.9% | — |
| Q4 25 | -3845.8% | — | ||
| Q3 25 | -5086.1% | -269.9% | ||
| Q2 25 | -7725.6% | -309.0% | ||
| Q1 25 | -8185.7% | -227.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | -7980.4% | -207.1% | ||
| Q2 24 | -1796.7% | -748.9% | ||
| Q1 24 | -2530.4% | -450.5% |
| Q4 25 | 6227.1% | — | ||
| Q3 25 | -50612.3% | -566.9% | ||
| Q2 25 | -22867.4% | -257.5% | ||
| Q1 25 | -7832.7% | -187.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | -7227.5% | -194.6% | ||
| Q2 24 | -885.7% | -698.3% | ||
| Q1 24 | -1863.7% | -415.3% |
| Q4 25 | $111.28 | — | ||
| Q3 25 | $-32.89 | $-0.25 | ||
| Q2 25 | $-79.73 | $-0.12 | ||
| Q1 25 | $-0.51 | $-0.24 | ||
| Q4 24 | — | — | ||
| Q3 24 | $-744.35 | $-0.29 | ||
| Q2 24 | $-485.30 | $-0.30 | ||
| Q1 24 | $-3.08 | $-0.29 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.3M | $45.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $300.9M | $15.3M |
| Total Assets | $303.9M | $50.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $7.3M | $45.1M | ||
| Q3 25 | $124.1M | $30.8M | ||
| Q2 25 | $6.1M | $32.4M | ||
| Q1 25 | $1.1M | $41.8M | ||
| Q4 24 | $1.1M | $30.3M | ||
| Q3 24 | $3.5M | $36.6M | ||
| Q2 24 | $6.4M | $41.4M | ||
| Q1 24 | $3.6M | $47.2M |
| Q4 25 | $300.9M | $15.3M | ||
| Q3 25 | $-152.4M | $6.0M | ||
| Q2 25 | $6.0M | $17.5M | ||
| Q1 25 | $1.3M | $5.1M | ||
| Q4 24 | $1.1M | $6.7M | ||
| Q3 24 | $3.8M | $34.3M | ||
| Q2 24 | $6.3M | $40.6M | ||
| Q1 24 | $2.0M | $46.1M |
| Q4 25 | $303.9M | $50.2M | ||
| Q3 25 | $475.9M | $36.1M | ||
| Q2 25 | $7.9M | $38.7M | ||
| Q1 25 | $3.5M | $48.2M | ||
| Q4 24 | $3.5M | $36.9M | ||
| Q3 24 | $5.6M | $40.4M | ||
| Q2 24 | $8.8M | $44.8M | ||
| Q1 24 | $5.8M | $51.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-16.5M | $-35.3M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | -0.05× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-16.5M | $-35.3M | ||
| Q3 25 | $-4.0M | $-6.2M | ||
| Q2 25 | $-2.8M | $-10.3M | ||
| Q1 25 | $-3.5M | $-9.0M | ||
| Q4 24 | $-11.0M | $-25.6M | ||
| Q3 24 | $-2.8M | $-5.1M | ||
| Q2 24 | $-2.9M | $-7.3M | ||
| Q1 24 | $-3.0M | $-5.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-11.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $-3.0M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -5970.8% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -2226.7% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.7% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 3.7% | — |
| Q4 25 | -0.05× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
